- Home
- ABEO vs BWFG Comparison
ABEO vs BWFG Comparison
Compare ABEO & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- BWFG
- Stock Information
- Founded
- ABEO 1974
- BWFG 2002
- Country
- ABEO United States
- BWFG United States
- Employees
- ABEO N/A
- BWFG N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- BWFG Major Banks
- Sector
- ABEO Health Care
- BWFG Finance
- Exchange
- ABEO Nasdaq
- BWFG Nasdaq
- Market Cap
- ABEO 289.2M
- BWFG 333.1M
- IPO Year
- ABEO 1980
- BWFG N/A
- Fundamental
- Price
- ABEO $5.49
- BWFG $41.19
- Analyst Decision
- ABEO Strong Buy
- BWFG Buy
- Analyst Count
- ABEO 6
- BWFG 2
- Target Price
- ABEO $18.17
- BWFG $42.00
- AVG Volume (30 Days)
- ABEO 1.0M
- BWFG 36.7K
- Earning Date
- ABEO 11-13-2025
- BWFG 10-23-2025
- Dividend Yield
- ABEO N/A
- BWFG 1.86%
- EPS Growth
- ABEO N/A
- BWFG N/A
- EPS
- ABEO 0.99
- BWFG 2.64
- Revenue
- ABEO $400,000.00
- BWFG $81,749,000.00
- Revenue This Year
- ABEO N/A
- BWFG $66.56
- Revenue Next Year
- ABEO $324.71
- BWFG $14.45
- P/E Ratio
- ABEO $5.69
- BWFG $16.25
- Revenue Growth
- ABEO N/A
- BWFG 0.32
- 52 Week Low
- ABEO $3.93
- BWFG $26.39
- 52 Week High
- ABEO $7.54
- BWFG $46.85
- Technical
- Relative Strength Index (RSI)
- ABEO 44.77
- BWFG 37.02
- Support Level
- ABEO $5.21
- BWFG $41.39
- Resistance Level
- ABEO $5.73
- BWFG $43.58
- Average True Range (ATR)
- ABEO 0.24
- BWFG 1.08
- MACD
- ABEO 0.06
- BWFG -0.39
- Stochastic Oscillator
- ABEO 55.05
- BWFG 6.15
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.